Dr. Ali-Asghar Zhumkhawala, MD

Dr. Zhumkhawala practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Zhumkhawala's NPI, 1124331723, was assigned on July 23, 2010. Dr. Zhumkhawala graduated from Feinberg School of Medicine in 2007. Dr. Zhumkhawala holds California license A107430.

Dr. Zhumkhawala's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Zhumkhawala's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Zhumkhawala is also affiliated with Emanate Health Foothill Presbyterian Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Zhumkhawala to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhumkhawala practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Zhumkhawala's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Zhumkhawala is board certified in urology by the American Board of Urology. Dr. Zhumkhawala is licensed in California.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Zhumkhawala treats.

CMS data shows 525 Medicare services from Dr. Zhumkhawala across 14 procedure codes in 2024, for 244 Medicare patients. Medicare paid $51,173 for them.

CMS counts 244 Medicare patients who saw Dr. Zhumkhawala in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhumkhawala's median patient age at 69, with 25% women.

In 2024, Dr. Zhumkhawala wrote 152 Medicare Part D claims for 70 patients. 88% of them were for generic drugs. CMS names the drug for 96 of them, across 3 drugs with 11 or more claims each, at $2,320 in total drug cost. In 2023, CMS named 106 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Zhumkhawala for performance year 2024, reported as part of a group. Dr. Zhumkhawala accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhumkhawala as offering telehealth. CMS counts 20 procedures of prostate resection by Dr. Zhumkhawala, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Zhumkhawala, published from 2015 to 2024. The most frequent topics are Cystectomy, Postoperative Complications and Robotic Surgical Procedures. Dr. Zhumkhawala's most frequent co-authors are Kevin G. Chan, MD, Bertram Emmanuel Yuh, MD and Clayton S. Lau, MD.

CMS Open Payments shows 42 general payments to Dr. Zhumkhawala from 13 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $3,203.

Dr. Zhumkhawala graduated from Feinberg School of Medicine in 2007.

Dr. Zhumkhawala is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.